A phase 2 clinical trial has demonstrated that bimagrumab, when combined with semaglutide, resulted in significant weight loss for trial participants while maintaining lean muscle mass suggesting a promising approach for Diabetes mellitusProgress and opportunities in the evolving epidemic: Cell PDF] Once weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double blind, placebo controlled and active controlled, dose finding phase 2 trial. Semantic Scholar Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5 NR4a1 axis Nature Communications